Anti-Sortilin Antibodies for Use in Therapy by Alector LLC
Summary
The European Patent Office published patent application EP3983441A1 for Alector LLC, covering anti-sortilin antibodies for therapeutic use in neurological conditions. The application was published April 15, 2026 under IPC classification C07K 16/28 (peptides, antibodies) with designations across 35 European states. Inventors include Robert Paul, Michael F. Ward, Hua Long, Shiao-Ping Lu, Omer Rizwan Siddiqui, Arnon Rosenthal, and Herve Rhinn.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 22 changes logged to date.
What changed
The EPO published patent application EP3983441A1 for anti-sortilin antibodies for use in therapy, filed by Alector LLC. The application covers therapeutic applications in neurological conditions including Alzheimer's disease and related dementias, as indicated by classification A61P 25/28.
For companies developing sortilin-targeted biologics or neuroprotective therapies, this publication signals potential freedom-to-operate considerations in European markets. Competitors should review the patent's claims upon grant to assess potential licensing needs or design-around options.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTI-SORTILIN ANTIBODIES FOR USE IN THERAPY
Publication EP3983441A1 Kind: A1 Apr 15, 2026
Applicants
Alector LLC
Inventors
PAUL, Robert, WARD, Michael F., LONG, Hua, LU, Shiao-Ping, SIDDIQUI, Omer Rizwan, ROSENTHAL, Arnon, RHINN, Herve
IPC Classifications
C07K 16/28 20060101AFI20201218BHEP G01N 33/53 20060101ALI20201218BHEP A61P 25/28 20060101ALI20201218BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.